All Biologic articles

  • Feb-24-Podcast-artwork-Webvision
    Podcasts

    RegRapPod − February 2024

    Vol.21 #2: In February 2024’s RegRapPod, host Alan Booth talks to Issue Editors Dejan Brkic and Esteban Herrero-Martinez about medtech.

  • Jan-24-Podcast-artwork-Webvision
    Podcasts

    RegRapPod − January 2024

    Vol.21 #1: In January 2024’s RegRapPod, host Alan Booth talks to Issue Editors Julie Warner and Ash Ramzan about biologics.

  • RR-Jan-2024-Cover
  • AdobeStock_281211016
    Journal

    CMC considerations for US biosimilars development

    2022-04-18T15:18:00Z

    The US Biologics Price Competition and Innovation Act of 2009 (BPCI Act) provides an abbreviated licensure pathway for biosimilar products. This pathway brought the hope of lower cost biologics, perhaps similar to what was accomplished by generics for small molecule drugs. Twelve years have now passed since the BPCI Act and experience continues to be gained with biosimilars development…